COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 14:00, il y a 6 mois 1 jour Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start Applied DNA Sciences and Alphazyme LLC collaborate to enhance manufacturing of Linea RNA polymerase to meet growing demand for Linea IVT platform. Project aims to increase RNAP manufacturing capacity and reduce unit costs Manufacturing Applied DNA Sciences Linea IVT Platform Alphazyme LLC Linea RNA Polymerase
BRÈVE publiée le 14/03/2024 à 15:05, il y a 6 mois 5 jours Applied DNA présentera des plateformes ADN avancées au Congrès mondial du vaccin Congrès Mondial Du Vaccin Sciences Appliquées De L'ADN Plateforme ADN Linea Plateforme Linea IVT Production D'ARNm
BRÈVE publiée le 14/03/2024 à 15:05, il y a 6 mois 5 jours Applied DNA to Present Advanced DNA Platforms at World Vaccine Congress Applied DNA Sciences World Vaccine Congress Linea DNA Platform Linea IVT Platform MRNA Production
COMMUNIQUÉ DE PRESSE publié le 14/03/2024 à 15:00, il y a 6 mois 5 jours Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress Applied DNA Sciences, Inc. will showcase Linea™ IVT and Linea™ DNA platforms at the 24th Annual World Vaccine Congress in Washington, D.C. Sales team available Applied DNA Sciences DNA Technologies World Vaccine Congress Linea DNA Linea IVT
COMMUNIQUÉ DE PRESSE publié le 08/02/2024 à 22:05, il y a 7 mois 11 jours Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
COMMUNIQUÉ DE PRESSE publié le 05/02/2024 à 19:00, il y a 7 mois 14 jours Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
COMMUNIQUÉ DE PRESSE publié le 02/02/2024 à 22:15, il y a 7 mois 17 jours Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
COMMUNIQUÉ DE PRESSE publié le 31/01/2024 à 14:00, il y a 7 mois 19 jours Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
COMMUNIQUÉ DE PRESSE publié le 14/12/2023 à 14:00, il y a 9 mois 5 jours Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
COMMUNIQUÉ DE PRESSE publié le 07/12/2023 à 22:05, il y a 9 mois 12 jours Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
Publié le 19/09/2024 à 17:45, il y a 9 heures 2 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 9 heures 2 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 9 heures 2 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 20/09/2024 à 02:00, il y a 47 minutes Academy of Math and Science Celebrates Hispanic Heritage Month
Publié le 19/09/2024 à 23:15, il y a 3 heures 32 minutes Cypher Metaverse Inc. Announces Second Closing of Financing
Publié le 19/09/2024 à 23:00, il y a 3 heures 47 minutes WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Publié le 19/09/2024 à 23:00, il y a 3 heures 47 minutes Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Publié le 19/09/2024 à 21:09, il y a 5 heures 37 minutes EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Publié le 19/09/2024 à 18:44, il y a 8 heures 3 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 19/09/2024 à 18:03, il y a 8 heures 44 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 19/09/2024 à 17:52, il y a 8 heures 54 minutes PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Publié le 19/09/2024 à 17:52, il y a 8 heures 54 minutes PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros